Quiescent Subpopulations of Human CD34-Positive Hematopoietic Stem Cells Are Preferred Targets for Stable Recombinant Adeno-Associated Virus Type 2 Transduction-Reference-Cited by-同舟云学术

Quiescent Subpopulations of Human CD34-Positive Hematopoietic Stem Cells Are Preferred Targets for Stable Recombinant Adeno-Associated Virus Type 2 Transduction

Published:2007-07 Issue:7 Volume:18 Page:614-626
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Paz Helicia¹,Wong Christie A.²,Li Wei¹,Santat Leah²,Wong K.K.¹²,Chatterjee Saswati¹

Affiliation:

1. Division of Virology, City of Hope National Medical Center and Beckman Research Institute, Duarte, CA 91010.

2. Division of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center and Beckman Research Institute, Duarte, CA 91010.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/hum.2006.188

Reference68 articles.

1. Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1

2. Regional intravascular delivery of AAV-2-F.IX to skeletal muscle achieves long-term correction of hemophilia B in a large animal model

3. No Evidence for Tumorigenesis of AAV Vectors in a Large-Scale Study in Mice

4. Cancer predisposition and hematopoietic failure in Rad50S/S mice

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adeno-Associated Virus and Hematopoietic Stem Cells: The Potential of Adeno-Associated Virus Hematopoietic Stem Cells in Genetic Medicines;Human Gene Therapy;2020-05-01

2. Efficient Nuclease-free HR by Clade F AAV Requires High MOIs with High Quality Vectors;Molecular Therapy;2019-12

3. Molecular characterization of novel Adeno-associated virus variants infecting human tissues;Virus Research;2019-10

4. Stem cell-derived clade F AAVs mediate high-efficiency homologous recombination-based genome editing;Proceedings of the National Academy of Sciences;2018-07-17

5. Genetic Manipulation of Hematopoietic Stem Cells;Thomas’ Hematopoietic Cell Transplantation;2016-01-01